Unequal Scrutiny in Pharma Ethics

Media coverage is heavily biased towards small pharmacies, highlighting their mistakes while often neglecting significant issues at large pharmaceutical companies. The lengthy inspection protocols for overseas manufacturing facilities limit the FDA's oversight, allowing companies like Eli Lilly and Pfizer to evade proper scrutiny despite serious past violations. As a result, public attention fixates on minor recalls by small operations, overshadowing major failures and systematic problems within the larger pharmaceutical industry, which remain largely unreported and uninvestigated.